Yahoo · Sep 2, 2026
Are Medical Stocks Lagging Cronos Group (CRON) This Year?
Here is how Cronos Group (CRON) and Curaleaf Holdings, Inc. (CURLF) have performed compared to their sector so far this year.
CR
NASDAQ · CRON
Cronos Group Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$3.14
Down-$0.02 (-0.63%)
Updated Sep 14, 2026, 12:33 PM
SID Score
5.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.09B
- P/E ratio
- 59.51
- Dividend yield
- 0.00%
- 52-week range
- $2.38 – $3.61
- Volume
- 710.83K
- Avg. volume
- 1.99M
Price performance
CRON price history
1M range · 19 trading sessions · Daily adjusted prices
CRON closed at $3.14 after 19 trading sessions, down 0.32% for the selected period.
- Last close
- $3.14
- Period change
- -0.32%
- Period low
- $3.14
- Period high
- $3.55
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $3.18 | $3.185 | $3.11 | $3.14 | 710.83K |
| Sep 10, 2026 | $3.12 | $3.19 | $3.12 | $3.16 | 584.73K |
| Sep 9, 2026 | $3.18 | $3.195 | $3.13 | $3.155 | 605.77K |
| Sep 8, 2026 | $3.24 | $3.255 | $3.17 | $3.185 | 929.83K |
| Sep 4, 2026 | $3.22 | $3.27 | $3.215 | $3.26 | 493.81K |
| Sep 3, 2026 | $3.28 | $3.29 | $3.21 | $3.26 | 1.18M |
| Sep 2, 2026 | $3.36 | $3.40 | $3.23 | $3.24 | 855.11K |
| Sep 1, 2026 | $3.34 | $3.42 | $3.33 | $3.38 | 1.12M |
| Aug 31, 2026 | $3.36 | $3.39 | $3.32 | $3.37 | 1.07M |
| Aug 28, 2026 | $3.40 | $3.4209 | $3.31 | $3.38 | 1.24M |
| Aug 27, 2026 | $3.55 | $3.6077 | $3.38 | $3.39 | 2.3M |
| Aug 26, 2026 | $3.49 | $3.58 | $3.48 | $3.55 | 1.42M |
| Aug 25, 2026 | $3.47 | $3.555 | $3.40 | $3.51 | 2.46M |
| Aug 24, 2026 | $3.31 | $3.45 | $3.27 | $3.41 | 2.22M |
| Aug 21, 2026 | $3.23 | $3.32 | $3.22 | $3.31 | 1.31M |
| Aug 20, 2026 | $3.275 | $3.299 | $3.21 | $3.22 | 998.13K |
| Aug 19, 2026 | $3.21 | $3.30 | $3.21 | $3.29 | 1.38M |
| Aug 18, 2026 | $3.14 | $3.24 | $3.13 | $3.21 | 1.05M |
| Aug 17, 2026 | $3.14 | $3.18 | $3.12 | $3.15 | 1.33M |
Latest CRON news
The latest Smart Investors Daily articles mentioning CRON.
Stock researchCompany · Overview
CRON research
Overview
Company profile and research snapshot.
Company profile
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $3.43
- Implied upside
- —
- Analysts
- 7
| Date | Firm | Rating | Target |
|---|---|---|---|
| May 11, 2026 | CANACCORD GENUITY | Buy | — |
| May 10, 2026 | TD COWEN | Buy | — |
| May 10, 2026 | ROTH CAPITAL PARTNERS | Buy | — |
| Mar 1, 2026 | TD COWEN | Buy | — |
| Feb 27, 2026 | ROTH CAPITAL PARTNERS | Buy | — |
News briefing
No generated briefing is available yet.
Yahoo · Sep 2, 2026
Cronos’ brand Spinach® Expands its Best-Selling Lineups of Edibles and Vapes
TORONTO, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, is expanding its lineup of edible multipacks with the SOURZ by Spinach® Blue Raspberry Lemonade Fully Blasted multipack, featuring its first live resin gummy. This month the brand will also launch new flavors in its best-selling lineup of vape cartridges, Strawberry Banana and Sweet Citrus Punch. The new SOURZ by Spinach® Blue Raspberry Lemonade Fully Blaste
SeekingAlpha · Aug 7, 2026
Cronos Group: This Cannabis Name Isn't Reliant On U.S. Legalization Efforts
SeekingAlpha · Aug 7, 2026
Cronos: Strong Quarter, And The Outlook For The Future Is Positive Thanks To M&A
Cronos Group (CRON) expands in Europe via CanAdelaar as revenue jumps 58% YoY. Click here to read my most recent analysis of CRON stock.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
